Cargando…

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

Inhalational anthrax has high mortality even with antibiotic treatment, and antitoxins are now recommended as an adjunct to standard antimicrobial regimens. The efficacy of obiltoxaximab, a monoclonal antibody against anthrax protective antigen (PA), was examined in multiple studies conducted in two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Brent J., Shadiack, Annette M., Carpenter, Sarah, Sanford, Daniel, Henning, Lisa N., O'Connor, Edward, Gonzales, Nestor, Mondick, John, French, Jonathan, Stark, Gregory V., Fisher, Alan C., Casey, Leslie S., Serbina, Natalya V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2016
Materias:	Clinical Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038317/ https://www.ncbi.nlm.nih.gov/pubmed/27431222 http://dx.doi.org/10.1128/AAC.00972-16

Ejemplares similares

Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax
por: Yamamoto, Brent J., et al.
Publicado: (2016)

Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule
por: Nagy, CF, et al.
Publicado: (2016)

Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen
por: Henning, Lisa N., et al.
Publicado: (2018)

Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans
por: Nagy, Christa F., et al.
Publicado: (2017)

Evaluating Detection of an Inhalational Anthrax Outbreak
por: Buckeridge, David L., et al.
Publicado: (2006)

Physiological Responses to Multiple Low-Doses of Bacillus anthracis Spores in the Rabbit Model of Inhalation Anthrax
por: Taft, Sarah C., et al.
Publicado: (2020)

Investigation of Inhalation Anthrax Case, United States
por: Griffith, Jayne, et al.
Publicado: (2014)

Raxibacumab: potential role in the treatment of inhalational anthrax
por: Kummerfeldt, Carlos E
Publicado: (2014)

Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection
por: Barnes, Kay B., et al.
Publicado: (2021)

Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge
por: Jakielaszek, Charles, et al.
Publicado: (2023)

Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long‐Acting β (2)‐Agonists and Inhaled Corticosteroids: The OUTPUL Study
por: Ferroni, Eliana, et al.
Publicado: (2016)

Physiological Responses to a Single Low-Dose of Bacillus anthracis Spores in the Rabbit Model of Inhalational Anthrax
por: Taft, Sarah C., et al.
Publicado: (2020)

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017)

CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance
por: Martinez, V G, et al.
Publicado: (2008)

The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax
por: Coggeshall, Kenneth Mark, et al.
Publicado: (2013)

A case report of inhalation anthrax acquired naturally
por: Azarkar, Zohreh, et al.
Publicado: (2016)

Quantitative Models of the Dose-Response and Time Course of Inhalational Anthrax in Humans
por: Toth, Damon J. A., et al.
Publicado: (2013)

Comprehensive characterization of toxins during progression of inhalation anthrax in a non-human primate model
por: Boyer, Anne E., et al.
Publicado: (2022)

Primary Involvement of Pharynx and Peyer's Patch in Inhalational and Intestinal Anthrax
por: Glomski, Ian J, et al.
Publicado: (2007)

Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001
por: Griffith, Kevin S., et al.
Publicado: (2003)

Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model
por: Lawrence, William S., et al.
Publicado: (2020)

Insights on β‐blockers for the treatment of hypertension: A survey of health care practitioners
por: Egan, Brent, et al.
Publicado: (2018)

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
por: Jara, Michele, et al.
Publicado: (2012)

Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection
por: Kunkel, M., et al.
Publicado: (2023)

Inhaled hypertonic saline in adults hospitalised for exacerbation of cystic fibrosis lung disease: a retrospective study
por: Pezzulo, Alejandro A, et al.
Publicado: (2012)

Lung B cells promote early pathogen dissemination and hasten death from inhalation anthrax
por: Rayamajhi, Manira, et al.
Publicado: (2012)

Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Yersinia pestis
por: Willix, Joshua L., et al.
Publicado: (2020)

Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
por: Plaunt, Adam J., et al.
Publicado: (2021)

Evidence for colorectal cancer cell specificity of aspirin effects on NFκB signalling and apoptosis
por: Din, F V N, et al.
Publicado: (2004)

Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis
por: Loke, Yoon K, et al.
Publicado: (2015)

Exogenous Interferon-α and Interferon-γ Increase Lethality of Murine Inhalational Anthrax
por: Gold, Jeffrey A., et al.
Publicado: (2007)

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.
por: Jernigan, J A, et al.
Publicado: (2001)

Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001
por: Holtz, Timothy H., et al.
Publicado: (2003)

Inhalational Anthrax Outbreak among Postal Workers, Washington, D.C., 2001
por: Dewan, Puneet K., et al.
Publicado: (2002)

Potential of subdermal solar energy harvesting for medical device applications based on worldwide meteorological data
por: Tholl, Maximilien V., et al.
Publicado: (2021)

Combination Therapy with Antibiotics and Anthrax Immune Globulin Intravenous (AIGIV) Is Potentially More Effective than Antibiotics Alone in Rabbit Model of Inhalational Anthrax
por: Kammanadiminti, Srinivas, et al.
Publicado: (2014)

Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes
por: Belfort-DeAguiar, Renata D., et al.
Publicado: (2015)

First Case of Bioterrorism-Related Inhalational Anthrax, Florida, 2001: North Carolina Investigation
por: Maillard, Jean-Marie, et al.
Publicado: (2002)

Estimation of Time Period for Effective Human Inhalational Anthrax Treatment Including Antitoxin Therapy
por: Rubinson, Lewis, et al.
Publicado: (2017)

Efficacy of ANTHRASIL (Anthrax Immune Globulin Intravenous (Human)) in rabbit and nonhuman primate models of inhalational anthrax: Data supporting approval under animal rule
por: Kammanadiminti, Srinivas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g8uo04brae4r907b1pgle9nb35